Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help

Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

  Sip Protocol

Masonic Cancer Research Center
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Back to Search Instructions

Protocol No. 2013LS104 Principal Investigator Miller, Weston
Phase Phase II
Age Group Both Scope Local
Secondary Protocol No. MT2013-31
Title MT2013-31:Allogeneic Hematopoietic Cell Transplantation for Inherited Metabolic Disorders and Severe Osteopetrosis following Conditioning with Busulfan (Therapeutic Drug Monitoring), Fludarabine +/- ATG
Applicable Disease Sites Non Cancer
Drugs Involved Anti-Thymocyte Globulin - Rabbit (ATG)
BUSULFAN (MYLERAN)
CYCLOPHOSPHAMIDE (CYTOXAN, NEOSAR)
CYCLOSPORIN
CYTOXAN (CYCLOPHOSPHAMIDE)
FLUDARABINE (FLUDARA)
METHYLPREDNISOLONE SODIUM SUCCINATE (SOLU-MEDROL)
MYCOPHENOLATE MOFETIL
Status Open
Participating Institutions Masonic Cancer Center
Treatment Type Non-Cancer Therapeutic
Contact Timothy Krepski Phone:612-273-2800
Email:tkrepsk1@fairview.org
Weston Miller Phone:612-626-2778
Email:mill4991@umn.edu
Patricia Kleinke Phone:612-273-0857
Email:pkleink1@fairview.org